An observational study in Stroke and Healthy Participants, sponsored by Pusan National University Yangsan Hospital. Active, not recruiting at 1 site in South Korea. Open to participants aged 19 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-07.
Sponsored by Pusan National University Yangsan Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 279 studies in Stroke with a site in Korea, Republic of — 41 open to participants now, 49 under way, 2 of them phase 3. Stroke · Korea, Republic of.
Among the 279 studies in Stroke with a site in Korea, Republic of, this one is the 56th largest by planned enrollment of the 61 observational ones that give a count, is one of 14 that started in 2025, is one of 62 observational ones, reaches primary completion later than 27 of the 48 other live ones, and was the 266th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →41 of the 279 studies in Stroke with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Seyoung Shin · Sites in Korea, Republic of
Ages 19+ · Healthy volunteers
Yonsei University · Sites in Korea, Republic of
Ages 19+
Yonsei University · Sites in Korea, Republic of
Ages 19–80
S&Ebio Co. Ltd. · Sites in Korea, Republic of
Ages 19+
Yonsei University · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 19 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
279 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 13 · Phase 3 38 · Phase 4 21
First in 2003; this study’s year is marked. 14 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 45 is below the median of 150 across 1,971 observational studies indexed under Stroke.
Median enrollment 50 across the 215 interventional studies, 150 across the 61 observational. Of the 177 that completed or were terminated, 28 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
60 of 279 have an industry lead sponsor. The 10 most frequent:
Pusan National University Yangsan Hospital is the lead sponsor of 108 studies on the registry; 27 are open to participants now.
Pusan National University Yangsan Hospital has 9 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
8 of the studies in Stroke with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07558876Jisu KimTask-Oriented Upper Limb Training With Focal Vibration in Stroke | 2026-12 |
| NCT06752096Navigantis Inc.Robot-Assisted Neurovascular Intervention | 2026-12-01 |
| NCT07570264Nunaps IncLEXURE for Post-Stroke Aphasia | 2026-12-30 |
| NCT07322107Pusan National University Yangsan HospitalPrefrontal Brain Activity and ECG Patterns in Stroke and Healthy Adults | 2026-12-31 |
| NCT07482579Seyoung ShinDevelopment of Stroke Prognosis Predictive Precision Medicine Based on a Digital Twin | 2026-12-31 |
Add all 8 to your calendar (.ics) → With an account.
Among the 279 studies in Stroke with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This observational study will evaluate brain activity and heart rhythm patterns in people with and without stroke. Brain activity will be measured using functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), and cardiac activity will be measured using electrocardiography (ECG). The goal is to characterize differences in prefrontal brain activation and ECG features between stroke patients and healthy adults
This study is an observational investigation designed to characterize neurophysiological and cardiovascular features in adults with a history of stroke and in age-matched healthy controls. Participants will undergo noninvasive measurements of brain activity using functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), focusing on prefrontal cortical responses during resting and simple task conditions. Electrocardiography (ECG) will be recorded concurrently to assess heart rate and rhythm characteristics, including temporal and spectral ECG parameters.
The primary objective is to compare patterns of prefrontal brain activation and ECG characteristics between stroke patients and healthy adults, exploring potential associations between altered cortical activity and cardiac autonomic regulation after stroke. Secondary aims include examining relationships between brain signals, ECG features, and clinical factors such as stroke severity or functional status in the patient group. Results from this study may help to generate hypotheses for future interventional research and to identify physiological markers useful for monitoring recovery or risk stratification in stroke survivors.
Adults aged 19 to 80 years, including patients with intracerebral hemorrhage, patients with cerebral infarction, and neurologically healthy adult volunteers who meet the study's inclusion and exclusion criteria
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults aged 19 to 80 years.
Diagnosed with intracerebral hemorrhage based on clinical evaluation and neuroimaging findings.
Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
Voluntarily agrees to participate in the study, provides written , and is able to participate for the entire study period.
Cerebral Infarction Group (Stroke Patients)
Adults aged 19 to 80 years.
Diagnosed with cerebral infarction (ischemic stroke) based on clinical evaluation and neuroimaging findings.
Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
Healthy Adult Group
Adults aged 19 to 80 years.
No history of stroke or (TIA).
No major stroke risk factors such as hypertension, diabetes mellitus, or hyperlipidemia.
No chronic diseases, including cardiovascular disease, chronic kidney disease, or chronic pulmonary disease.
No psychiatric disorders, such as depression or schizophrenia.
Not taking medications that may affect cerebral hemodynamics, including antihypertensive agents, anticoagulants, antiplatelet agents, or antidepressants.
Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
Exclusion Criteria:
History of head trauma or cranial surgery within the past 6 months with wounds that have not yet fully healed.
Current diagnosis of a severe psychiatric disorder, such as schizophrenia, major depressive disorder, or bipolar disorder.
Participation in another clinical study and intake of an drug within the past 30 days.
Women who are pregnant or breastfeeding.
Presence of an acute infection or inflammatory disease.
Inability to adequately understand the study procedures or lack of voluntary consent to participate.
Any other finding that, in the judgment of the principal investigator or designated study physician, makes the individual unsuitable for participation in this study.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adults with a history of intracerebral hemorrhagic stroke. Participants undergo noninvasive measurements of prefrontal brain activity using fNIRS and EEG, and cardiac activity using ECG, to characterize neurophysiological and electrocardiographic features.
Adults with a history of cerebral infarction (ischemic stroke). Participants receive the same fNIRS, EEG, and ECG assessments as the hemorrhagic stroke group to compare patterns of brain activation and ECG characteristics.
Neurologically healthy adults without a history of stroke or major cardiovascular disease. Participants undergo identical fNIRS, EEG, and ECG measurements to serve as a comparison group for stroke patients.
Resting-State Prefrontal EEG Activity
Quantitative characteristics of resting-state electroencephalographic (EEG) activity recorded from the prefrontal cortex (Fp1, Fp2, F7, F8) using a 10-20 electrode placement system during 10 minutes of eyes-closed rest. EEG is obtained once for each participant in one of three groups (intracerebral hemorrhage, cerebral infarction, healthy adults) within a 30-minute session including approximately 10 minutes of preparation, 10 minutes of recording, and 10 minutes of completion procedures.
Time frame: Single assessment at one visit (approximately 30-minute session).
Resting-State Prefrontal fNIRS Oxygenation
Changes in oxy-hemoglobin and deoxy-hemoglobin concentrations in the prefrontal cortex (corresponding to Fp1, Fp2, F7, F8) measured by functional near-infrared spectroscopy (fNIRS) during 10 minutes of eyes-closed rest. fNIRS is performed once for each participant in the same 30-minute session (about 10 minutes preparation, 10 minutes recording, 10 minutes completion) in one of the three groups.
Time frame: Single assessment at one visit (approximately 30-minute session).
Resting-State Electrocardiographic Parameters
Electrocardiographic (ECG) characteristics recorded for 10 minutes during eyes-closed rest, using electrodes attached to the ears and both wrists, including heart rate, rhythm, and time- and frequency-domain indices of heart rate variability. ECG is measured once for each participant during the same 30-minute session (around 10 minutes preparation, 10 minutes recording, 10 minutes completion) in one of the three groups.
Time frame: Single assessment at one visit (approximately 30-minute session).
Plan to share: No — Individual participant data (IPD) cannot be shared due to protection of participants' personal infand regulatory restrictions of our hospital.
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.
Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 13 months is below that.
Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pusan National University Yangsan Hospital →